Industry: Medical Devices & Consumables
Published Date: 2025-03-10
Pages: 139 Pages
Report ld: 4617039
Request Sample
Customized Report
Microfluidic Chip in Biomedical Field Market Size(US$)

CAGR 2025-2031
9.8%
Market Size,2031
USD 10,170
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Microfluidic Chip in Biomedical Field was estimated to be worth US$ 5335 million in 2024 and is forecast to a readjusted size of US$ 10170 million by 2031 with a CAGR of 9.8% during the forecast period 2025-2031.
Microfluidic chip in biomedical field is an integrated chip that integrates microscale channels and microfluidic technology, which is specially used in biomedical research, biological analysis and biological detection. In the biomedical field, microfluidic chips integrate or basically integrate the basic operating units such as sample preparation, reaction, separation, detection, cell culture, sorting, and lysis involved in fields such as chemistry and biology onto a chip of a few square centimeters or even smaller. A network is formed by microchannels, and controllable fluids run through the entire system to realize various functions of different laboratories such as conventional chemistry, biology, materials, and optics.
This report aims to provide a comprehensive presentation of the global market for Microfluidic Chip in Biomedical Field, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Microfluidic Chip in Biomedical Field by region & country, by Type, and by Application.
The Microfluidic Chip in Biomedical Field market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microfluidic Chip in Biomedical Field.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Microfluidic Chip in Biomedical Field manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Microfluidic Chip in Biomedical Field in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Microfluidic Chip in Biomedical Field in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Microfluidic Chip in Biomedical Field Product Introduction
1.2 Global Microfluidic Chip in Biomedical Field Market Size Forecast
1.2.1 Global Microfluidic Chip in Biomedical Field Sales Value (2020-2031)
1.2.2 Global Microfluidic Chip in Biomedical Field Sales Volume (2020-2031)
1.2.3 Global Microfluidic Chip in Biomedical Field Sales Price (2020-2031)
1.3 Microfluidic Chip in Biomedical Field Market Trends & Drivers
1.3.1 Microfluidic Chip in Biomedical Field Industry Trends
1.3.2 Microfluidic Chip in Biomedical Field Market Drivers & Opportunity
1.3.3 Microfluidic Chip in Biomedical Field Market Challenges
1.3.4 Microfluidic Chip in Biomedical Field Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Microfluidic Chip in Biomedical Field Players Revenue Ranking (2024)
2.2 Global Microfluidic Chip in Biomedical Field Revenue by Company (2020-2025)
2.3 Global Microfluidic Chip in Biomedical Field Players Sales Volume Ranking (2024)
2.4 Global Microfluidic Chip in Biomedical Field Sales Volume by Company Players (2020-2025)
2.5 Global Microfluidic Chip in Biomedical Field Average Price by Company (2020-2025)
2.6 Key Manufacturers Microfluidic Chip in Biomedical Field Manufacturing Base and Headquarters
2.7 Key Manufacturers Microfluidic Chip in Biomedical Field Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Microfluidic Chip in Biomedical Field
2.9 Microfluidic Chip in Biomedical Field Market Competitive Analysis
2.9.1 Microfluidic Chip in Biomedical Field Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Microfluidic Chip in Biomedical Field Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microfluidic Chip in Biomedical Field as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Silicon Material
3.1.2 Polymer Material
3.2 Global Microfluidic Chip in Biomedical Field Sales Value by Type
3.2.1 Global Microfluidic Chip in Biomedical Field Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Microfluidic Chip in Biomedical Field Sales Value, by Type (2020-2031)
3.2.3 Global Microfluidic Chip in Biomedical Field Sales Value, by Type (%) (2020-2031)
3.3 Global Microfluidic Chip in Biomedical Field Sales Volume by Type
3.3.1 Global Microfluidic Chip in Biomedical Field Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Microfluidic Chip in Biomedical Field Sales Volume, by Type (2020-2031)
3.3.3 Global Microfluidic Chip in Biomedical Field Sales Volume, by Type (%) (2020-2031)
3.4 Global Microfluidic Chip in Biomedical Field Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Disease Diagnosis
4.1.2 Drug Development
4.1.3 Cell Culture and Analysis
4.1.4 Other
4.2 Global Microfluidic Chip in Biomedical Field Sales Value by Application
4.2.1 Global Microfluidic Chip in Biomedical Field Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Microfluidic Chip in Biomedical Field Sales Value, by Application (2020-2031)
4.2.3 Global Microfluidic Chip in Biomedical Field Sales Value, by Application (%) (2020-2031)
4.3 Global Microfluidic Chip in Biomedical Field Sales Volume by Application
4.3.1 Global Microfluidic Chip in Biomedical Field Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Microfluidic Chip in Biomedical Field Sales Volume, by Application (2020-2031)
4.3.3 Global Microfluidic Chip in Biomedical Field Sales Volume, by Application (%) (2020-2031)
4.4 Global Microfluidic Chip in Biomedical Field Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Microfluidic Chip in Biomedical Field Sales Value by Region
5.1.1 Global Microfluidic Chip in Biomedical Field Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Microfluidic Chip in Biomedical Field Sales Value by Region (2020-2025)
5.1.3 Global Microfluidic Chip in Biomedical Field Sales Value by Region (2026-2031)
5.1.4 Global Microfluidic Chip in Biomedical Field Sales Value by Region (%), (2020-2031)
5.2 Global Microfluidic Chip in Biomedical Field Sales Volume by Region
5.2.1 Global Microfluidic Chip in Biomedical Field Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Microfluidic Chip in Biomedical Field Sales Volume by Region (2020-2025)
5.2.3 Global Microfluidic Chip in Biomedical Field Sales Volume by Region (2026-2031)
5.2.4 Global Microfluidic Chip in Biomedical Field Sales Volume by Region (%), (2020-2031)
5.3 Global Microfluidic Chip in Biomedical Field Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Microfluidic Chip in Biomedical Field Sales Value, 2020-2031
5.4.2 North America Microfluidic Chip in Biomedical Field Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Microfluidic Chip in Biomedical Field Sales Value, 2020-2031
5.5.2 Europe Microfluidic Chip in Biomedical Field Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Microfluidic Chip in Biomedical Field Sales Value, 2020-2031
5.6.2 Asia Pacific Microfluidic Chip in Biomedical Field Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Microfluidic Chip in Biomedical Field Sales Value, 2020-2031
5.7.2 South America Microfluidic Chip in Biomedical Field Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Microfluidic Chip in Biomedical Field Sales Value, 2020-2031
5.8.2 Middle East & Africa Microfluidic Chip in Biomedical Field Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Microfluidic Chip in Biomedical Field Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Microfluidic Chip in Biomedical Field Sales Value and Sales Volume
6.2.1 Key Countries/Regions Microfluidic Chip in Biomedical Field Sales Value, 2020-2031
6.2.2 Key Countries/Regions Microfluidic Chip in Biomedical Field Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Microfluidic Chip in Biomedical Field Sales Value, 2020-2031
6.3.2 United States Microfluidic Chip in Biomedical Field Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Microfluidic Chip in Biomedical Field Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Microfluidic Chip in Biomedical Field Sales Value, 2020-2031
6.4.2 Europe Microfluidic Chip in Biomedical Field Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Microfluidic Chip in Biomedical Field Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Microfluidic Chip in Biomedical Field Sales Value, 2020-2031
6.5.2 China Microfluidic Chip in Biomedical Field Sales Value by Type (%), 2024 VS 2031
6.5.3 China Microfluidic Chip in Biomedical Field Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Microfluidic Chip in Biomedical Field Sales Value, 2020-2031
6.6.2 Japan Microfluidic Chip in Biomedical Field Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Microfluidic Chip in Biomedical Field Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Microfluidic Chip in Biomedical Field Sales Value, 2020-2031
6.7.2 South Korea Microfluidic Chip in Biomedical Field Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Microfluidic Chip in Biomedical Field Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Microfluidic Chip in Biomedical Field Sales Value, 2020-2031
6.8.2 Southeast Asia Microfluidic Chip in Biomedical Field Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Microfluidic Chip in Biomedical Field Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Microfluidic Chip in Biomedical Field Sales Value, 2020-2031
6.9.2 India Microfluidic Chip in Biomedical Field Sales Value by Type (%), 2024 VS 2031
6.9.3 India Microfluidic Chip in Biomedical Field Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Agilent Technologies
7.1.1 Agilent Technologies Company Information
7.1.2 Agilent Technologies Introduction and Business Overview
7.1.3 Agilent Technologies Microfluidic Chip in Biomedical Field Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Agilent Technologies Microfluidic Chip in Biomedical Field Product Offerings
7.1.5 Agilent Technologies Recent Development
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Information
7.2.2 Thermo Fisher Scientific Introduction and Business Overview
7.2.3 Thermo Fisher Scientific Microfluidic Chip in Biomedical Field Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Thermo Fisher Scientific Microfluidic Chip in Biomedical Field Product Offerings
7.2.5 Thermo Fisher Scientific Recent Development
7.3 Illumina
7.3.1 Illumina Company Information
7.3.2 Illumina Introduction and Business Overview
7.3.3 Illumina Microfluidic Chip in Biomedical Field Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Illumina Microfluidic Chip in Biomedical Field Product Offerings
7.3.5 Illumina Recent Development
7.4 Dolomite Microfluidics
7.4.1 Dolomite Microfluidics Company Information
7.4.2 Dolomite Microfluidics Introduction and Business Overview
7.4.3 Dolomite Microfluidics Microfluidic Chip in Biomedical Field Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Dolomite Microfluidics Microfluidic Chip in Biomedical Field Product Offerings
7.4.5 Dolomite Microfluidics Recent Development
7.5 Micronit
7.5.1 Micronit Company Information
7.5.2 Micronit Introduction and Business Overview
7.5.3 Micronit Microfluidic Chip in Biomedical Field Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Micronit Microfluidic Chip in Biomedical Field Product Offerings
7.5.5 Micronit Recent Development
7.6 Bosch
7.6.1 Bosch Company Information
7.6.2 Bosch Introduction and Business Overview
7.6.3 Bosch Microfluidic Chip in Biomedical Field Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Bosch Microfluidic Chip in Biomedical Field Product Offerings
7.6.5 Bosch Recent Development
7.7 microfluidic ChipShop
7.7.1 microfluidic ChipShop Company Information
7.7.2 microfluidic ChipShop Introduction and Business Overview
7.7.3 microfluidic ChipShop Microfluidic Chip in Biomedical Field Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 microfluidic ChipShop Microfluidic Chip in Biomedical Field Product Offerings
7.7.5 microfluidic ChipShop Recent Development
7.8 Fluigent
7.8.1 Fluigent Company Information
7.8.2 Fluigent Introduction and Business Overview
7.8.3 Fluigent Microfluidic Chip in Biomedical Field Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Fluigent Microfluidic Chip in Biomedical Field Product Offerings
7.8.5 Fluigent Recent Development
7.9 BioFluidix
7.9.1 BioFluidix Company Information
7.9.2 BioFluidix Introduction and Business Overview
7.9.3 BioFluidix Microfluidic Chip in Biomedical Field Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 BioFluidix Microfluidic Chip in Biomedical Field Product Offerings
7.9.5 BioFluidix Recent Development
7.10 WenHao Microfluidic Technology
7.10.1 WenHao Microfluidic Technology Company Information
7.10.2 WenHao Microfluidic Technology Introduction and Business Overview
7.10.3 WenHao Microfluidic Technology Microfluidic Chip in Biomedical Field Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 WenHao Microfluidic Technology Microfluidic Chip in Biomedical Field Product Offerings
7.10.5 WenHao Microfluidic Technology Recent Development
7.11 TinKer BioTechnology
7.11.1 TinKer BioTechnology Company Information
7.11.2 TinKer BioTechnology Introduction and Business Overview
7.11.3 TinKer BioTechnology Microfluidic Chip in Biomedical Field Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 TinKer BioTechnology Microfluidic Chip in Biomedical Field Product Offerings
7.11.5 TinKer BioTechnology Recent Development
7.12 Dingxu Micro Control
7.12.1 Dingxu Micro Control Company Information
7.12.2 Dingxu Micro Control Introduction and Business Overview
7.12.3 Dingxu Micro Control Microfluidic Chip in Biomedical Field Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Dingxu Micro Control Microfluidic Chip in Biomedical Field Product Offerings
7.12.5 Dingxu Micro Control Recent Development
7.13 Chongqing Chuangxin Biotechnology
7.13.1 Chongqing Chuangxin Biotechnology Company Information
7.13.2 Chongqing Chuangxin Biotechnology Introduction and Business Overview
7.13.3 Chongqing Chuangxin Biotechnology Microfluidic Chip in Biomedical Field Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Chongqing Chuangxin Biotechnology Microfluidic Chip in Biomedical Field Product Offerings
7.13.5 Chongqing Chuangxin Biotechnology Recent Development
7.14 Shenzhen Mindray Bio-Medical Electronics
7.14.1 Shenzhen Mindray Bio-Medical Electronics Company Information
7.14.2 Shenzhen Mindray Bio-Medical Electronics Introduction and Business Overview
7.14.3 Shenzhen Mindray Bio-Medical Electronics Microfluidic Chip in Biomedical Field Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Shenzhen Mindray Bio-Medical Electronics Microfluidic Chip in Biomedical Field Product Offerings
7.14.5 Shenzhen Mindray Bio-Medical Electronics Recent Development
7.15 Beijing Kerui Technology
7.15.1 Beijing Kerui Technology Company Information
7.15.2 Beijing Kerui Technology Introduction and Business Overview
7.15.3 Beijing Kerui Technology Microfluidic Chip in Biomedical Field Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Beijing Kerui Technology Microfluidic Chip in Biomedical Field Product Offerings
7.15.5 Beijing Kerui Technology Recent Development
7.16 ThinXXS Microtechnology
7.16.1 ThinXXS Microtechnology Company Information
7.16.2 ThinXXS Microtechnology Introduction and Business Overview
7.16.3 ThinXXS Microtechnology Microfluidic Chip in Biomedical Field Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 ThinXXS Microtechnology Microfluidic Chip in Biomedical Field Product Offerings
7.16.5 ThinXXS Microtechnology Recent Development
7.17 Dolomite Bio
7.17.1 Dolomite Bio Company Information
7.17.2 Dolomite Bio Introduction and Business Overview
7.17.3 Dolomite Bio Microfluidic Chip in Biomedical Field Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Dolomite Bio Microfluidic Chip in Biomedical Field Product Offerings
7.17.5 Dolomite Bio Recent Development
7.18 Elveflow
7.18.1 Elveflow Company Information
7.18.2 Elveflow Introduction and Business Overview
7.18.3 Elveflow Microfluidic Chip in Biomedical Field Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Elveflow Microfluidic Chip in Biomedical Field Product Offerings
7.18.5 Elveflow Recent Development
7.19 uFluidix
7.19.1 uFluidix Company Information
7.19.2 uFluidix Introduction and Business Overview
7.19.3 uFluidix Microfluidic Chip in Biomedical Field Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 uFluidix Microfluidic Chip in Biomedical Field Product Offerings
7.19.5 uFluidix Recent Development
8 Industry Chain Analysis
8.1 Microfluidic Chip in Biomedical Field Industrial Chain
8.2 Microfluidic Chip in Biomedical Field Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Microfluidic Chip in Biomedical Field Sales Model
8.5.2 Sales Channel
8.5.3 Microfluidic Chip in Biomedical Field Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Microfluidic Chip in Biomedical Field market is projected to grow from US$ 5806 million in 2025 to US$ 11060 million by 2032, at a CAGR of 9.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 180
USD 4900.00
(Single User License)
The global Microfluidic Chip in Biomedical Field market size was US$ 5806 million in 2025 and is forecast to reach a readjusted size of US$ 11060 million by 2032 with a CAGR of 9.8% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 109
USD 4250.00
(Single User License)
The global Microfluidic Chip in Biomedical Field market was valued at US$ 5806 million in 2025 and is anticipated to reach US$ 11060 million by 2032, at a CAGR of 9.8% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 137
USD 2900.00
(Single User License)
The global market for Microfluidic Chip in Biomedical Field was estimated to be worth US$ 5806 million in 2025 and is projected to reach US$ 11060 million, growing at a CAGR of 9.8% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 133
USD 3950.00
(Single User License)
The global Microfluidic Chip in Biomedical Field market is projected to grow from US$ 5335 million in 2024 to US$ 10170 million by 2031, at a CAGR of 9.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 172
USD 4900.00
(Single User License)
The global Microfluidic Chip in Biomedical Field market size was US$ 5335 million in 2024 and is forecast to a readjusted size of US$ 10170 million by 2031 with a CAGR of 9.8% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 105
USD 4250.00
(Single User License)
The global market for Microfluidic Chip in Biomedical Field was valued at US$ 5335 million in the year 2024 and is projected to reach a revised size of US$ 10170 million by 2031, growing at a CAGR of 9.8% during the forecast period.
Published Date: 2025-03-10
Pages: 99
USD 2900.00
(Single User License)
The global Microfluidic Chip in Biomedical Field revenue was US$ 4860 million in 2023 and is forecast to a readjusted size of US$ 9344 million by 2030 with a CAGR of 9.8% during the review period (2024-2030).
Published Date: 2024-08-22
Pages: 160
USD 4350.00
(Single User License)
The global Microfluidic Chip in Biomedical Field market is projected to grow from US$ 5335 million in 2024 to US$ 9344 million by 2030, at a Compound Annual Growth Rate (CAGR) of 9.8% during the forecast period.
Published Date: 2024-08-22
Pages: 184
USD 4900.00
(Single User License)
The global Microfluidic Chip in Biomedical Field market was valued at US$ 4860 million in 2023 and is anticipated to reach US$ 9344 million by 2030, witnessing a CAGR of 9.8% during the forecast period 2024-2030.
Published Date: 2024-08-22
Pages: 103
USD 2900.00
(Single User License)
The global Microfluidic Chip in Biomedical Field market is projected to grow from US$ 5806 million in 2025 to US$ 11060 million by 2032, at a CAGR of 9.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 180
The global Microfluidic Chip in Biomedical Field market size was US$ 5806 million in 2025 and is forecast to reach a readjusted size of US$ 11060 million by 2032 with a CAGR of 9.8% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 109
The global Microfluidic Chip in Biomedical Field market was valued at US$ 5806 million in 2025 and is anticipated to reach US$ 11060 million by 2032, at a CAGR of 9.8% from 2026 to 2032.
Published: 2026-01-09
Pages: 137
The global market for Microfluidic Chip in Biomedical Field was estimated to be worth US$ 5806 million in 2025 and is projected to reach US$ 11060 million, growing at a CAGR of 9.8% from 2026 to 2032.
Published: 2026-01-09
Pages: 133
The global Microfluidic Chip in Biomedical Field market is projected to grow from US$ 5335 million in 2024 to US$ 10170 million by 2031, at a CAGR of 9.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 172
The global Microfluidic Chip in Biomedical Field market size was US$ 5335 million in 2024 and is forecast to a readjusted size of US$ 10170 million by 2031 with a CAGR of 9.8% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 105
The global market for Microfluidic Chip in Biomedical Field was valued at US$ 5335 million in the year 2024 and is projected to reach a revised size of US$ 10170 million by 2031, growing at a CAGR of 9.8% during the forecast period.
Published: 2025-03-10
Pages: 99
The global Microfluidic Chip in Biomedical Field revenue was US$ 4860 million in 2023 and is forecast to a readjusted size of US$ 9344 million by 2030 with a CAGR of 9.8% during the review period (2024-2030).
Published: 2024-08-22
Pages: 160
The global Microfluidic Chip in Biomedical Field market is projected to grow from US$ 5335 million in 2024 to US$ 9344 million by 2030, at a Compound Annual Growth Rate (CAGR) of 9.8% during the forecast period.
Published: 2024-08-22
Pages: 184
The global Microfluidic Chip in Biomedical Field market was valued at US$ 4860 million in 2023 and is anticipated to reach US$ 9344 million by 2030, witnessing a CAGR of 9.8% during the forecast period 2024-2030.
Published: 2024-08-22
Pages: 103
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now